Contrast Media Injectors Market Trends, Industry & Size 2031
Global Contrast Media Injectors Market
Segments - by Products {Injector Systems (CT Injectors, MRI Injectors, and DSA Injectors), Consumables (Syringes, Tubes, and Others), Accessories}, Injector Types (Dual-Head Injectors, Single-Head Injectors, and Syringeless Injectors), Applications (Radiology, Interventional Radiology, and Interventional Cardiology), End-Users (Hospitals, Diagnostic Centers, and Ambulatory Surgery Centers), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 – 2027
Segments - by Products {Injector Systems (CT Injectors, MRI Injectors, and DSA Injectors), Consumables (Syringes, Tubes, and Others), Accessories}, Injector Types (Dual-Head Injectors, Single-Head Injectors, and Syringeless Injectors), Applications (Radiology, Interventional Radiology, and Interventional Cardiology), End-Users (Hospitals, Diagnostic Centers, and Ambulatory Surgery Centers), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 – 2027
The global contrast media injectors market was valued at USD 1,027.9 Million in 2019 and is projected to reach USD 1,589.7 Million by 2027, expanding at a CAGR of 6.8% during the forecast period. Demand for contrast media injectors is driven by the increasing demand for non-invasive and minimally invasive surgeries, growing incidence of several chronic diseases, rising research and development activities in the healthcare sector, and rising approvals for contrast agents.
Contrast media injectors are used to inject contrast media to improve the perfusion in tissues and blood. Contrast media injectors are used to inject contrast media at the time of diagnostic imaging to enhance image quality and improve patient safety.
Thus, the increase in the number of cancer and CVD cases will stimulate the demand for improved healthcare facilities and advanced diagnostic imaging procedures, which, in turn, will drive the market for contrast media injectors.
Contrast Media Injectors Market Dynamics
Non-invasive and minimally invasive surgical procedures provide several advantages, such as tiny incisions instead of a large opening, quick recovery, less hospital stays, less pain, and minor surgical wounds. The use of contrast media injectors in these procedures offers high-quality real-time imaging of the surgical site and ensures the treatment of appropriate area by surgeons.
Thus, the adoption of contrast media injectors for minimally invasive surgeries is increasing, which is further fueling the market.
Cases of chronic diseases requiring accurate diagnosis through different imaging systems such as computed tomography (CT) scanners and magnetic resonance imaging (MRI) equipment that requires contrast media injectors. Growing adoption of poor lifestyle is increasing incidences of chronic diseases, which is projected to drive the contrast media injectors market during the forecast period.
The contrast media injector market is expected to grow, due to the increasing expenditure on healthcare sector, and adoption of advanced diagnostics. Research and development areas of contrast media involves development of contrast media, and optimization of imaging technology for maximizing image contrast media. Moreover, the presence of various key vendors and their research and development (R&D) investments boost the growth of the market.
Rising demand for contrast agents has significantly increased over the past years, and introduction of Clariscan increases clinical offering for the US radiologists, that enhances visualization for providing better patient care. For instance, the U.S.
Food and Drug Administration (FDA) has approved Clariscan is a macrocyclic, gadolinium-based, ionic, magnetic resonance imaging (MRI) contrast agent. It has been approved in more than 55 countries across the world and more than 4 Million patient doses shipped in different countries. Hence, rising number of contrast agent approvals are propelling the market.
Rivalry amongst competitors has led to high pressure on pricing strategies. Moreover, the high costs of system and side-effects of contrast agents including iodinated contrast, gadolinium, barium, and microbubble agents, is expected to limit their adoption by healthcare professionals.
The cost of contrast media injectors differs, based on the types of injectors such as dual-head, single-head, and syringeless injectors. Also, cost of consumables is high as tube and syringe cannot be used again, due to hygiene and safety issues. This is a major burden for end users, thus the aforementioned factors are hampering the growth of contrast media injectors market.
Use of medical imaging as well as contrast media is expected to increase worldwide, due to rising use of computed tomography (CT), magnetic resonance imaging (MRI) and angiography procedures, and disease burdens. Rising awareness of early diagnosis of disease is expected to further drive the contrast media injectors market.
Increasing awareness about patient disease diagnosis helps the population to support imaging diagnostic systems. Hence, lucrative growth opportunities in the CT scanners and MRI equipment are expected to boost the market.
Contrast Media Injectors Market Segmental Outlook
In terms of products, the contrast media injectors market is divided into injector systems, consumables, and accessories. The injector system is further divided into CT injectors, MRI injectors, and DSA injectors.
The consumables segment is further segmented into syringes, tubes, and others. The consumables segment is expected to hold a significant share of the market and is projected to expand at a substantial CAGR during the forecast period, owing to rising requirement of consumables in order to maintain hygienic and safety conditions during diagnostic procedures.
The CT injector sub-segment is expected to expand at a considerable CAGR, owing to the widespread application of CT injectors in cancer surgery, cardiovascular surgery, neurosurgery, and spinal procedures. Moreover, growing adoption of minimally invasive surgeries is projected to boost the demand for CT injectors during the forecast period.
Based on injector types, the contrast media injectors market is categorized as dual-head injectors, single-head injectors, and syringeless injectors. The syringeless injectors segment is expected to expand at a significant pace during the forecast period, due to its advantages such as high efficiency, user-friendliness, and minimum wastage of contrast media.
Moreover, leading market players of contrast media injectors are concentrating on the development of syringeless injectors, which in turn, is anticipated to drive the segment. The single-head injectors segment is expected to hold a significant share of the market and is projected to expand at a substantial CAGR during the forecast period, as it is widely used for CT, angiography, and MRI.
In terms of applications, the contrast media injectors market is segmented into radiology, interventional radiology, and interventional cardiology. The radiology segment is expected to expand at a significant pace during the forecast period, due to increasing number of radiology techniques using contrast media injectors.
The growth of the segment is attributed to the diagnosis of several diseases, including breast cancer, heart conditions, broken bones, colon cancer, gastrointestinal conditions, and blood clots. The interventional cardiology segment is expected to grow at a significant pace, owing to increasing prevalence of cardiac diseases, including heart valve problems, arrhythmia, heart attacks, and strokes
In terms of end-users, the contrast media injectors market is categorized as hospitals, diagnostic centers, and Ambulatory Surgery Centers (ASCs). The hospital segment is projected to expand at a considerable pace during the forecast period, due to rising admissions of patients suffering from cardiovascular diseases, cancer, and neurological disorders.
The diagnostic centers segment is expected to grow at a significant CAGR, owing to surging number of private imaging centers (driven by the increasing demand for diagnostic imaging and early diagnosis) and the absence of imaging modalities in mid-scale and small hospitals.
Growing focus on the expansion of healthcare infrastructure in developing countries in Africa and Asia Pacific is anticipated to propel the hospital segment.
Contrast Media Injectors Market Regional Outlook
On the basis of regions, the global contrast media injectors market is fragmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is expected to dominate the market during the forecast period, due to factors such as growing incidence of minimally invasive procedures and rising prevalence of chronic diseases owing to changing lifestyles.
The US holds significant share in the market during the forecast period, due to technological advancements in contrast media injectors devices and increasing expenditure by key players along with rising regulatory approvals.
Europe region hold substantial share in the market during the forecast period, due to the local presence of various leading companies, such as Bracco Group, and others. The market in China is expected to expand at a rapid CAGR during the forecast period, due to rising disposable income and increase in funding for research and development (R&D).
Key Benefits for Industry Participants & Stakeholders
In-depth analysis of the global contrast media injectors market
Historical, current, and projected market size in terms of value (USD million) and volume (tons)
Potential & niche segments and regions exhibiting promising growth covered
Industry drivers, restraints, and opportunities covered in the study
Prominent manufacturers operational in the global contrast media injectors market include Bracco, Bayer AG, Guerbet, Shenzhen Anke High-tech Co., Ltd., Nemoto Kyorindo co., Ltd., Sino Medical-Device Technology Co., Ltd., and Imaxeon.
These companies are considered as key manufacturers of contrast media injectors based on their revenue, research & development (R&D) activities, regional presence, and supply chain management system.
Chapter 1 Executive Summary Chapter 2 Assumptions and Acronyms Used Chapter 3 Research Methodology Chapter 4 Contrast Media Injectors Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Contrast Media Injectors Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Contrast Media Injectors Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Contrast Media Injectors Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Contrast Media Injectors Market Size & Volume & Forecast, 2017-2027 4.5.1 Contrast Media Injectors Market Size & Volume and Y-o-Y Growth 4.5.2 Contrast Media Injectors Market Absolute $ Opportunity 4.6 Pricing Analysis & Forecast, By Product, Region, and Country, 2017-2027 4.7 Regulatory Requirements 4.8 Reimbursement Scenario 4.9 Technological Trends & Advancements Overview 4.10 Business Model of Key Companies 4.11 Installed Base By Country: CT, MRI, DSA Scanning Machines Chapter 5 Global Contrast Media Injectors Market Analysis and Forecast By Products 5.1 Introduction 5.1.1 Key Market Trends & Growth Opportunities By Products 5.1.2 Basis Point Share (BPS) Analysis By Products 5.1.3 Absolute $ Opportunity Assessment By Products 5.2 Contrast Media Injectors Market Size & Volume Forecast By Products 5.2.1 Injector Systems 5.2.1.1 CT Injectors 5.2.1.2 MRI Injectors 5.2.1.3 DSA Injectors 5.2.2 Consumables 5.2.2.1 Syringes 5.2.2.2 Tubes 5.2.2.3 Others 5.2.3 Accessories 5.3 Market Attractiveness Analysis By Products Chapter 6 Global Contrast Media Injectors Market Analysis and Forecast By Injector Types 6.1 Introduction 6.1.1 Key Market Trends & Growth Opportunities By Injector Types 6.1.2 Basis Point Share (BPS) Analysis By Injector Types 6.1.3 Absolute $ Opportunity Assessment By Injector Types 6.2 Contrast Media Injectors Market Size & Volume Forecast By Injector Types 6.2.1 Single-head Injectors 6.2.2 Dual-head Injectors 6.2.3 Syringeless Injectors 6.3 Market Attractiveness Analysis By Injector Types Chapter 7 Global Contrast Media Injectors Market Analysis and Forecast By Applications 7.1 Introduction 7.1.1 Key Market Trends & Growth Opportunities By Applications 7.1.2 Basis Point Share (BPS) Analysis By Applications 7.1.3 Absolute $ Opportunity Assessment By Applications 7.2 Contrast Media Injectors Market Size & Volume Forecast By Applications 7.2.1 Radiology 7.2.2 Interventional Radiology 7.2.3 Interventional Cardiology 7.3 Market Attractiveness Analysis By Applications Chapter 8 Global Contrast Media Injectors Market Analysis and Forecast By End-Users 8.1 Introduction 8.1.1 Key Market Trends & Growth Opportunities By End-Users 8.1.2 Basis Point Share (BPS) Analysis By End-Users 8.1.3 Absolute $ Opportunity Assessment By End-Users 8.2 Contrast Media Injectors Market Size & Volume Forecast By End-Users 8.2.1 Hospitals 8.2.2 Diagnostic Centers 8.2.3 Ambulatory Surgery Centers (ASCs) 8.3 Market Attractiveness Analysis By End-Users Chapter 9 Global Contrast Media Injectors Market Analysis and Forecast by Region 9.1 Introduction 9.1.1 Key Market Trends & Growth Opportunities by Region 9.1.2 Basis Point Share (BPS) Analysis by Region 9.1.3 Absolute $ Opportunity Assessment by Region 9.2 Contrast Media Injectors Market Size & Volume Forecast by Region 9.2.1 North America 9.2.2 Europe 9.2.3 Asia Pacific 9.2.4 Latin America 9.2.5 Middle East & Africa (MEA) 9.3 Market Attractiveness Analysis by Region Chapter 10 Coronavirus Disease (COVID-19) Impact 10.1 Introduction 10.2 Current & Future Impact Analysis 10.3 Economic Impact Analysis 10.4 Government Policies 10.5 Investment Scenario Chapter 11 North America Contrast Media Injectors Analysis and Forecast 11.1 Introduction 11.2 North America Contrast Media Injectors Market Size & Volume Forecast by Country 11.2.1 U.S. 11.2.2 Canada 11.3 Basis Point Share (BPS) Analysis by Country 11.4 Absolute $ Opportunity Assessment by Country 11.5 Market Attractiveness Analysis by Country 11.6 North America Contrast Media Injectors Market Size & Volume Forecast By Products 11.6.1 Injector Systems 11.6.1.1 CT Injectors 11.6.1.2 MRI Injectors 11.6.1.3 DSA Injectors 11.6.2 Consumables 11.6.2.1 Syringes 11.6.2.2 Tubes 11.6.2.3 Others 11.6.3 Accessories 11.7 Basis Point Share (BPS) Analysis By Products 11.8 Absolute $ Opportunity Assessment By Products 11.9 Market Attractiveness Analysis By Products 11.10 North America Contrast Media Injectors Market Size & Volume Forecast By Injector Types 11.10.1 Single-head Injectors 11.10.2 Dual-head Injectors 11.10.3 Syringeless Injectors 11.11 Basis Point Share (BPS) Analysis By Injector Types 11.12 Absolute $ Opportunity Assessment By Injector Types 11.13 Market Attractiveness Analysis By Injector Types 11.14 North America Contrast Media Injectors Market Size & Volume Forecast By Applications 11.14.1 Radiology 11.14.2 Interventional Radiology 11.14.3 Interventional Cardiology 11.15 Basis Point Share (BPS) Analysis By Applications 11.16 Absolute $ Opportunity Assessment By Applications 11.17 Market Attractiveness Analysis By Applications 11.18 North America Contrast Media Injectors Market Size & Volume Forecast By End-Users 11.18.1 Hospitals 11.18.2 Diagnostic Centers 11.18.3 Ambulatory Surgery Centers (ASCs) 11.19 Basis Point Share (BPS) Analysis By End-Users 11.20 Absolute $ Opportunity Assessment By End-Users 11.21 Market Attractiveness Analysis By End-Users Chapter 12 Europe Contrast Media Injectors Analysis and Forecast 12.1 Introduction 12.2 Europe Contrast Media Injectors Market Size & Volume Forecast by Country 12.2.1 Germany 12.2.2 France 12.2.3 Italy 12.2.4 U.K. 12.2.5 Spain 12.2.6 Russia 12.2.7 Rest of Europe 12.3 Basis Point Share (BPS) Analysis by Country 12.4 Absolute $ Opportunity Assessment by Country 12.5 Market Attractiveness Analysis by Country 12.6 Europe Contrast Media Injectors Market Size & Volume Forecast By Products 12.6.1 Injector Systems 12.6.1.1 CT Injectors 12.6.1.2 MRI Injectors 12.6.1.3 DSA Injectors 12.6.2 Consumables 12.6.2.1 Syringes 12.6.2.2 Tubes 12.6.2.3 Others 12.6.3 Accessories 12.7 Basis Point Share (BPS) Analysis By Products 12.8 Absolute $ Opportunity Assessment By Products 12.9 Market Attractiveness Analysis By Products 12.10 Europe Contrast Media Injectors Market Size & Volume Forecast By Injector Types 12.10.1 Single-head Injectors 12.10.2 Dual-head Injectors 12.10.3 Syringeless Injectors 12.11 Basis Point Share (BPS) Analysis By Injector Types 12.12 Absolute $ Opportunity Assessment By Injector Types 12.13 Market Attractiveness Analysis By Injector Types 12.14 Europe Contrast Media Injectors Market Size & Volume Forecast By Applications 12.14.1 Radiology 12.14.2 Interventional Radiology 12.14.3 Interventional Cardiology 12.15 Basis Point Share (BPS) Analysis By Applications 12.16 Absolute $ Opportunity Assessment By Applications 12.17 Market Attractiveness Analysis By Applications 12.18 Europe Contrast Media Injectors Market Size & Volume Forecast By End-Users 12.18.1 Hospitals 12.18.2 Diagnostic Centers 12.18.3 Ambulatory Surgery Centers (ASCs) 12.19 Basis Point Share (BPS) Analysis By End-Users 12.20 Absolute $ Opportunity Assessment By End-Users 12.21 Market Attractiveness Analysis By End-Users Chapter 13 Asia Pacific Contrast Media Injectors Analysis and Forecast 13.1 Introduction 13.2 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast by Country 13.2.1 China 13.2.2 Japan 13.2.3 South Korea 13.2.4 India 13.2.5 Australia 13.2.6 South East Asia (SEA) 13.2.7 Rest of Asia Pacific (APAC) 13.2.8 Indonesia 13.2.9 Vietnam 13.2.10 Pakistan 13.2.11 Philippines 13.3 Basis Point Share (BPS) Analysis by Country 13.4 Absolute $ Opportunity Assessment by Country 13.5 Market Attractiveness Analysis by Country 13.6 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By Products 13.6.1 Injector Systems 13.6.1.1 CT Injectors 13.6.1.2 MRI Injectors 13.6.1.3 DSA Injectors 13.6.2 Consumables 13.6.2.1 Syringes 13.6.2.2 Tubes 13.6.2.3 Others 13.6.3 Accessories 13.7 Basis Point Share (BPS) Analysis By Products 13.8 Absolute $ Opportunity Assessment By Products 13.9 Market Attractiveness Analysis By Products 13.10 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By Injector Types 13.10.1 Single-head Injectors 13.10.2 Dual-head Injectors 13.10.3 Syringeless Injectors 13.11 Basis Point Share (BPS) Analysis By Injector Types 13.12 Absolute $ Opportunity Assessment By Injector Types 13.13 Market Attractiveness Analysis By Injector Types 13.14 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By Applications 13.14.1 Radiology 13.14.2 Interventional Radiology 13.14.3 Interventional Cardiology 13.15 Basis Point Share (BPS) Analysis By Applications 13.16 Absolute $ Opportunity Assessment By Applications 13.17 Market Attractiveness Analysis By Applications 13.18 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By End-Users 13.18.1 Hospitals 13.18.2 Diagnostic Centers 13.18.3 Ambulatory Surgery Centers (ASCs) 13.19 Basis Point Share (BPS) Analysis By End-Users 13.20 Absolute $ Opportunity Assessment By End-Users 13.21 Market Attractiveness Analysis By End-Users Chapter 14 Latin America Contrast Media Injectors Analysis and Forecast 14.1 Introduction 14.2 Latin America Contrast Media Injectors Market Size & Volume Forecast by Country 14.2.1 Brazil 14.2.2 Mexico 14.2.3 Rest of Latin America (LATAM) 14.3 Basis Point Share (BPS) Analysis by Country 14.4 Absolute $ Opportunity Assessment by Country 14.5 Market Attractiveness Analysis by Country 14.6 Latin America Contrast Media Injectors Market Size & Volume Forecast By Products 14.6.1 Injector Systems 14.6.1.1 CT Injectors 14.6.1.2 MRI Injectors 14.6.1.3 DSA Injectors 14.6.2 Consumables 14.6.2.1 Syringes 14.6.2.2 Tubes 14.6.2.3 Others 14.6.3 Accessories 14.7 Basis Point Share (BPS) Analysis By Products 14.8 Absolute $ Opportunity Assessment By Products 14.9 Market Attractiveness Analysis By Products 14.10 Latin America Contrast Media Injectors Market Size & Volume Forecast By Injector Types 14.10.1 Single-head Injectors 14.10.2 Dual-head Injectors 14.10.3 Syringeless Injectors 14.11 Basis Point Share (BPS) Analysis By Injector Types 14.12 Absolute $ Opportunity Assessment By Injector Types 14.13 Market Attractiveness Analysis By Injector Types 14.14 Latin America Contrast Media Injectors Market Size & Volume Forecast By Applications 14.14.1 Radiology 14.14.2 Interventional Radiology 14.14.3 Interventional Cardiology 14.15 Basis Point Share (BPS) Analysis By Applications 14.16 Absolute $ Opportunity Assessment By Applications 14.17 Market Attractiveness Analysis By Applications 14.18 Latin America Contrast Media Injectors Market Size & Volume Forecast By End-Users 14.18.1 Hospitals 14.18.2 Diagnostic Centers 14.18.3 Ambulatory Surgery Centers (ASCs) 14.19 Basis Point Share (BPS) Analysis By End-Users 14.20 Absolute $ Opportunity Assessment By End-Users 14.21 Market Attractiveness Analysis By End-Users Chapter 15 Middle East & Africa (MEA) Contrast Media Injectors Analysis and Forecast 15.1 Introduction 15.2 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast by Country 15.2.1 Saudi Arabia 15.2.2 South Africa 15.2.3 UAE 15.2.4 Rest of Middle East & Africa (MEA) 15.2.5 Turkey 15.2.6 Iran 15.2.7 Iraq 15.3 Basis Point Share (BPS) Analysis by Country 15.4 Absolute $ Opportunity Assessment by Country 15.5 Market Attractiveness Analysis by Country 15.6 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By Products 15.6.1 Injector Systems 15.6.1.1 CT Injectors 15.6.1.2 MRI Injectors 15.6.1.3 DSA Injectors 15.6.2 Consumables 15.6.2.1 Syringes 15.6.2.2 Tubes 15.6.2.3 Others 15.6.3 Accessories 15.7 Basis Point Share (BPS) Analysis By Products 15.8 Absolute $ Opportunity Assessment By Products 15.9 Market Attractiveness Analysis By Products 15.10 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By Injector Types 15.10.1 Single-head Injectors 15.10.2 Dual-head Injectors 15.10.3 Syringeless Injectors 15.11 Basis Point Share (BPS) Analysis By Injector Types 15.12 Absolute $ Opportunity Assessment By Injector Types 15.13 Market Attractiveness Analysis By Injector Types 15.14 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By Applications 15.14.1 Radiology 15.14.2 Interventional Radiology 15.14.3 Interventional Cardiology 15.15 Basis Point Share (BPS) Analysis By Applications 15.16 Absolute $ Opportunity Assessment By Applications 15.17 Market Attractiveness Analysis By Applications 15.18 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By End-Users 15.18.1 Hospitals 15.18.2 Diagnostic Centers 15.18.3 Ambulatory Surgery Centers (ASCs) 15.19 Basis Point Share (BPS) Analysis By End-Users 15.20 Absolute $ Opportunity Assessment By End-Users 15.21 Market Attractiveness Analysis By End-Users Chapter 16 Competition Landscape 16.1 Contrast Media Injectors Market: Competitive Dashboard 16.2 Global Contrast Media Injectors Market: Market Share Analysis, 2019 16.3 Company Profiles (Details - Overview, Financials, Developments, Strategy) 16.3.1 ulrich GmbH & Co. KG 16.3.2 GENERAL ELECTRIC COMPANY 16.3.3 Bayer HealthCare LLC 16.3.4 Bracco Imaging S.p.A. 16.3.5 Guerbet 16.3.6 SINO MDT 16.3.7 APOLLO RT Co. Ltd. 16.3.8 Shenzhen Anke High-tech Co., Ltd. 16.3.9 Shenzhen Seacrown Electromechanical Co., Ltd 16.3.10 Nemoto Kyorindo Co., Ltd. 16.3.11 Smiths Group plc 16.3.12 AngioDynamics 16.3.13 MEDTRON AG 16.3.14 Company 14 16.3.15 Company 15
Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization
Our Clients
Client Testinomials
We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you. Strategy Head of Major Tech Company
We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality. Major Player in Defense Industry
Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions. CMO of Leading Packaging Company from USA
I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data. Founder and Managing Partner of Major Korean Company
Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports. Global Consulting Firm
Major Manufactures are ulrich GmbH & Co. KG, GENERAL ELECTRIC COMPANY, Bayer HealthCare LLC, Bracco Imaging S.p.A., Guerbet, SINO MDT, APOLLO RT Co. Ltd.
The base year considered for the global contrast media injectors market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.
Demand for contrast media injectors is expected to continue to increase over the forecast period, taking into account increasing demand for non-invasive and minimally invasive surgeries, increasing occurrence of several chronic diseases, rising research and development activities in the healthcare sector, and rising approvals for contrast agents.
In addition to market size (in USD Million) and market volume (in Thousand Units), company market share (in % for base year 2019), other data such as Pricing Analysis & Forecast, By Product, Region, and Country; Regulatory Requirements, Reimbursement Scenario, Technological Trends & Advancements Overview, Business Model of Key Companies, Installed Base By Country: CT, MRI, DSA Scanning Machines, macro-economic factors and COVID-19 impact on the value chain are available in the final report.
According to the Growth Market Reports, the market for contrast media injectors is likely to register a CAGR of 6.8% during forecast period 2020-2027, with an anticipated valuation of USD 1,589.7 million by the end of 2027.
Request For Customization
Enquiry Before Buying
Speak With Analyst
